Medistim sent out a notification on the 21st of March regarding the annual report and a notification the 23rd of March with notice of general meeting in Medistim ASA where the same Annual report was attached. The file attachment with the annual report in the English version included some track changes. Attached is a clean version of the annual report. The agenda for the general meeting and attendance form is also attached.
The notification from 21st of March:
The Board of Medistim ASA has approved the Annual Accounts for 2017. The Annual Accounts are without changes from the preliminary Annual Accounts published on the 15th of February 2018. The Annual General Meeting will be held on 25th of April 2018, and the board has suggested a dividend of NOK 2.00 per share. Given that the General Meeting approves the suggested dividend, the share will be listed ex dividend NOK 2.00 per share on the 26th of April 2018. The annual report for 2017 is attached, and the Annual Report for 2017 will also be published on the company's website.
The notification from 21st of March:
Medistim ASA is giving notice of ordinary general meeting the 25th of April 2018. The meeting starts at 10.00 and is held at the company office at Økernveien 94 in Oslo. Attached is the agenda for the meeting and attendance form. Attached is also the annual report for 2017. The Board of Director's have suggested a dividend of NOK 2.00 per share. If the general meeting approves the suggested dividend it will go to the registered shareholders by the end of the day the 25th of April. This means that the shares in Medistim ASA will be traded ex dividend NOK 2.00 from 26th of April 2018.